A carregar...
Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report
BACKGROUND: Although the BCR-ABL tyrosine kinase inhibitor dasatinib is a potent treatment for chronic myeloid leukaemia, it is associated with the risk of dasatinib-induced pulmonary arterial hypertension (DASA-PAH), for which predisposing factors have yet to be elucidated. However, animal studies...
Na minha lista:
| Publicado no: | Eur Heart J Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6439368/ https://ncbi.nlm.nih.gov/pubmed/31020267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjcr/ytz025 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|